Home/Filings/4/0000899243-23-005736
4//SEC Filing

Trigilio Jeffrey 4

Accession 0000899243-23-005736

CIK 0001789972other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 7:01 PM ET

Size

12.2 KB

Accession

0000899243-23-005736

Insider Transaction Report

Form 4
Period: 2023-02-17
Trigilio Jeffrey
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-02-17+47,00088,402 total
  • Award

    Stock Option (Right to Buy)

    2023-02-17+93,50093,500 total
    Exercise: $11.34Exp: 2033-02-16Common Stock (93,500 underlying)
Footnotes (2)
  • [F1]The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
  • [F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Issuer

Cullinan Oncology, Inc.

CIK 0001789972

Entity typeother

Related Parties

1
  • filerCIK 0001838671

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 7:01 PM ET
Size
12.2 KB